SBWIC
AGN

Schaper Benz & Wise Investment Counsel’s Allergan plc AGN Stock Holding History

Schaper Benz & Wise Investment Counsel’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,822
Closed -$443K – 120
2017
Q2 		$443K Buy
+1,822
New +$428K 0.07% 90

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Schaper Benz & Wise Investment Counsel's AGN Position: Q3 2017 in Review

Schaper Benz & Wise Investment Counsel sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 1,822 shares — an estimated $443K sold.

Schaper Benz & Wise Investment Counsel first reported a position in AGN in Q2 2017 and held it in 1 quarter. The position peaked at $443K in Q2 2017. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Schaper Benz & Wise Investment Counsel reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Schaper Benz & Wise Investment Counsel sold 1,822 Allergan plc shares in Q3 2017, an estimated $443K.
  • Schaper Benz & Wise Investment Counsel first reported a position in Allergan plc in Q2 2017 and held it in 1 quarter.
  • Schaper Benz & Wise Investment Counsel's Allergan plc position peaked at $443K in Q2 2017.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Schaper Benz & Wise Investment Counsel's 13F filing for Q3 2017, filed 2 Nov 2017.